Neoleukin Therapeutics (NASDAQ:NLTX) Hits New 52-Week High – What’s Next?
Neoleukin Therapeutics, Inc. (NASDAQ:NLTX – Get Free Report)’s share price reached a new 52-week high on Monday . The stock traded as high as $74.49 and last traded at $71.53, with a volume of 315873 shares changing hands. The stock had previously closed at $68.21. Neoleukin Therapeutics Price Performance The company has a market cap […]
More Stories
Shopify (NYSE:SHOP) Given New $110.00 Price Target at Truist Financial
Shopify (NYSE:SHOP – Get Free Report) (TSE:SHOP) had its price objective hoisted by research analysts at Truist Financial from $65.00...
Merck & Co., Inc. (NYSE:MRK) Shares Sold by D Orazio & Associates Inc.
D Orazio & Associates Inc. decreased its holdings in Merck & Co., Inc. (NYSE:MRK – Free Report) by 3.3% in...
Sen. John Thune Elected Senate GOP Leader
By Mark Tapscott WASHINGTON—Senate Republicans on Wednesday selected Sen. John Thune of South Dakota as their new leader in the...
Terns Pharmaceuticals (NASDAQ:TERN) Price Target Raised to $7.50
Terns Pharmaceuticals (NASDAQ:TERN – Get Free Report) had its price objective increased by stock analysts at HC Wainwright from $5.50...
Camtek (NASDAQ:CAMT) Posts Quarterly Earnings Results, Beats Expectations By $0.06 EPS
Camtek (NASDAQ:CAMT – Get Free Report) posted its earnings results on Tuesday. The semiconductor company reported $0.75 earnings per share...
Ondas (NASDAQ:ONDS) Announces Quarterly Earnings Results
Ondas (NASDAQ:ONDS – Get Free Report) announced its quarterly earnings data on Tuesday. The company reported ($0.15) earnings per share...